NL-OMON44399已完成不适用
A proof of concept study for [18F]FB-IL2 PET imaging of infiltrating T cells after renal transplantation; a diagnostic tool for acute rejection - IL2 PET for renal transplant rejection
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Female or male aged between 18 and 80 years.
- •The patient understands the purpose and risks of the study and has given written informed consent to participate in the study.
- •All patients will have a clinical indication for renal biopsy.
排除标准
- •Patients with multiple-organ transplants.
- •Female patients who are pregnant or unwilling to use adequate contraception during the study.
- •Altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent.
- •A clinical reason for an immediate start of a therapeutic intervention with immunosuppressive medication.
研究者
相似试验
进行中（未招募）
1 期
Efficacy and safety of prednisone in the treatment of idiosyncratic hepatotoxicityCTIS2024-513004-33-00Fundacion Publica Andaluza Para La Investigacion De Malaga En Biomedicina Y Salud60
已完成
2 期
A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and AngiogenesisHigh-grade GliomaHead & Neck CancerLung CancerMelanomaSarcomaNCT00565721GE Healthcare33
进行中（未招募）
不适用
A Phase IIa, Proof of Concept Study to Evaluate the Reduction in Inflammatory Biomarkers and Assess Airway Function Following Administration of IMD-1041 in Patients with Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)MedDRA version: 9.1Level: LLTClassification code 10010952Term: COPDEUCTR2008-001889-81-GBInstitute of Medicinal Molecular Design, Inc.50
Unknown
早期 1 期
FDG and FDOPA PET Demonstration of Functional Brain AbnormalitiesGlioblastomaNCT04315584University of Virginia5
进行中（未招募）
不适用
Proof-of-concept phase II study to evaluate the anti-tumoractivity of sorafenib along with pathological and molecularchanges in tumor samples from patientswith resectable hepatocellular carcinoma. - BIOSHAREHepatocellular carcinoma resectableMedDRA version: 12.1Level: LLTClassification code 10019830Term: Hepatocellular carcinoma resectableEUCTR2009-018058-44-FRGERCOR